

























































Acta Derm Venereol 2020; 100: adv00060
This is an open access article under the CC BY-NC license. www.medicaljournals.se/acta
Journal Compilation © 2020 Acta Dermato-Venereologica.
doi: 10.2340/00015555-3404
Mutations in the Secreted LY6/urokinase-type plasminogen 
activator receptor (uPAR)-related protein 1 gene (SLURP1) 
cause the recessively inherited palmoplantar keratodermas 
(PPK) Mal de Meleda (MDM, MIM 248300) and Gam-
borg-Nielsen (GN, MIM 244850 (1–5). MDM is characte-
rized by diffuse progressive and transgredient erythematous 
PPK, typically starting in infancy. Hyperkeratotic plaques 
on the elbows and knees, nail dystrophy, perioral erythema, 
brachydactyly, and conical-shaped fingers are reported, as 
well as, rarely, constriction rings with spontaneous auto-am-
putation of digits. Hyperhidrosis and bacterial or fungal 
superinfection can result in malodorous macerations, and 
reduced mobility of the hands and feet is common (6, 7).
GN is milder than MDM, characterized by a diffuse and 
transgredient hyperkeratosis with an erythematous border, 
and sometimes with tapered fingers (1–3, 5). The nails are 
normal. Distal hyperkeratosis is present only on the knuckle 
pads (5).
Most MDM patients are homozygous for c.82del 
p.(Cys28Alafs*5), c.43T>C p.(Trp15Arg) and c.286C>T 
p.(Arg96*) (4, 7–9), while GN patients are typically ho-
mozygous for a missense mutation c.43T>C p.(Trp15Arg) 
(5). The c.82del p.(Cys28Alafs*5) variant was reported in 
Croatian, Tunisian and Algerian families and in a Scottish 
patient, suggesting a founder effect (9). This paper extends 
the SLURP1 spectrum by describing phenotypic variation 
in 3 unrelated patients with diffuse PPK, and reporting 2 
new SLURP1 mutations. 
CASE REPORTS
Case 1. An 8-year-old Finnish boy presented with diffuse waxy 
yellow PPK with a slight erythematous border since infancy (Table 
SI1). Progressive hyperkeratosis was noted on the dorsal surface of 
his fingers and toes, and on his knees and elbows (Fig. 1 and Fig. 
S11). Minor wounds left hyperkeratotic scars, and water exposure 
turned the hyperkeratosis white and spongy. All nails were brittle 
with longitudinal ridges, and his teeth had enamel defects. Whole 
exome sequencing (Appendix S11) revealed a maternally inherited 
missense mutation, c.178G>A p.(Glu60Lys) (rs200727790) in 
exon 2 and a paternally inherited in-frame deletion c.218_220del 
p.(Cys73del) (rs748879163) in exon 3 of SLURP1 ( Fig. S21). 
The p.(Glu60Lys) variant was predicted probably damaging by 
Polyphen and tolerated by SIFT (10). A total of 29 heterozygous 
p.(Glu60Lys) carriers, yielding a worldwide population allele 
frequency of 0.0001037, were reported in the GnomAD popula-
tion allele frequency database (https://gnomad.
broadinstitute. org; last accessed 20 August 
2019). There were 20  Finnish carriers  (al-
lele frequency 0.0008481). No homozygotes 
were reported. Only 1 Finnish heterozygous 
carrier for p.(Cys73del) was reported (Gno-
mAD Finnish population allele frequency 
0.000005250, worldwide population allele 
frequency 0.000004117).
Case 2. A 44-year-old Finnish woman had dif-
fuse, non-progressive PPK since infancy with 
a waxy yellow hyperkeratosis with an erythe-
matous border (Table SI1). The hyperkeratosis 
expanded on the dorsal surface of her hands 
and feet, and a hyperkeratotic plaque was also 
present on the elbow (Fig. 1 and Fig. S11). 
She had hyperhidrosis of the hands, feet and 
armpits and frequent dermatophyte infections 
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Fig. 1. Patient phenotypes. (a–c) phenotype of case 
1 c.178G>A p.(Glu60Lys) / c.218_220 p.(Cys73del), 
(d–f) phenotype of case 2 c.178G>A p.(Glu60Lys), and 



























































on the affected skin. All nails were clubbed and hyperkeratotic. 
On water exposure the affected skin turned white and spongy. 
A PPK gene panel (Appendix S11) revealed homozygosity for 
SLURP1 c.178G>A p.(Glu60Lys) (Fig. S21). Haplotype analysis 
revealed that case 1, his mother, and case 2 shared a haplotype 
of approximately 3,000 kb (chr8:142544410-145535881 (hg37)) 
surrounding the c.178G>A p.(Glu60Lys) variant, suggesting 
common ancestry.
Case 3. An 11-year-old Romanian boy presented with a waxy dif-
fuse PPK with a slight erythematous border without transgrediens 
and progrediens since the age of 2 years (Fig. 1, Table SI1). There 
was no nail, hair or tooth involvement. A custom gene panel revea-
led compound heterozygous mutations for a paternally inherited 
SLURP1 frameshift deletion in exon 2, c.82del p.(Cys28Alafs*5) 
(rs587776601) and a maternally inherited truncating mutation in 
exon 3 c.286C>T p.(Arg96*) (rs121908317). The former causes 
a premature stop codon at amino acid position 32 and the latter 
results in the deletion of cysteine involved in the highly conser-
ved disulphide bridges (4). Both have previously been reported 
homozygous in Algerian and Croatian MDM patients (4). Skin 
biopsies of all 3 cases revealed prominent hyperkeratosis with a 
very compact cornified layer, epidermal acanthosis with a pro-
nounced granular layer and elongation of the rete ridges (Fig. S31). 
No conclusive immunohistochemistry was possible for SLURP1.
DISCUSSION
We report 3 PPK patients with SLURP1 mutations and a 
phenotype sharing aspects of MDM and GN. Their PPK is 
characterized by a waxy moderately thick diffuse hyperke-
ratosis with an erythematous border similar to GN, although 
cases 1 and 2 have elbow and knee hyperkeratosis with 
nail abnormalities, which are rarely seen in GN, but rather 
in MDM. Otherwise, the manifestations are distinct ly less 
severe than MDM, lacking, e.g. erythematous inflammation 
and hyperkeratosis extending widely beyond palms and 
soles, pseudoainhum, reduction of motility and perioral 
erythema. Case 3 has the mildest phenotype, with only 
palmoplantar hyperkeratosis. A novel feature of cases 1 
and 2 is the aquagenic whitening of PPK not previously 
reported with MDM or GN. Our cases share similarities 
with milder diffuse PPK phenotypes described previously 
with SLURP1 mutations c.43T>C p.(Trp15Arg) and 
c.256G>A p.(Gly86Arg) (9, 11, 12). We identified 2 new 
SLURP1 PPK-associated variants c.178G>A p.(Glu60Lys) 
and c.218_220del p.(Cys73del), which are located in the 
central loop II region of SLURP1 (10). In SLURP2 the 
corresponding loop is critical in a complex formation with 
its receptors (13). The c.178G>A p.(Glu60Lys) is in the 
vicinity of the Tyr61–Pro62 peptide bond responsible for 
the conformational exchange in SLURP1 structure (10). The 
deleted Cys73 forms a disulphide bond with Cys43 in loop 
I of SLURP1, which may stabilize the antiparallel β-sheet 
structures in SLURP1 (10, 14). An 8-fold higher allele fre-
quency of the c.178G>A variant in the Finns indicates an 
enrichment in Finland and the shared ~3,000 kb haplotype 
in its carriers suggest a Finnish founder effect.
In conclusion, we further expand the spectrum of 
SLURP1 mutations with 2 novel mutations c.218_220del 
p.(Cys73del) and c.178G>A p.(Glu60Lys), the latter being 
a plausible Finnish founder mutation. Most importantly, the 
phenotypes of the cases reported here share features of both 
MDM and GN, thus verifying that these 2 can be seen as a 
single entity with large phenotypic variability. This suggests 
that SLURP1 might be involved in PPK mimicking KRT1 
or KRT9 mutations.
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